1. Ultrasonic particles: An approach for targeted gene delivery
- Author
-
Karlheinz Peter, Henry N. Gordon, Aidan P.G. Walsh, and Xiaowei Wang
- Subjects
PEI, polyethylenimine ,BNT162b2, BioNTech COVID-19 mRNA vaccine ,medicine.medical_treatment ,Genetic enhancement ,microbubble ,Pharmaceutical Science ,DSPE-PEG2000, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[polyethylene glycol-2000] ,VCAM-1, vascular cell adhesion molecule-1 ,Targeted therapy ,DNA, deoxyribonucleic acid ,miRNA, microRNA ,Medicine ,Ultrasonics ,sonoporation ,Molecular Targeted Therapy ,gene transfer ,CD105, endoglin, cluster of differentiation 105 ,MAdCAM-1, mucosal addressin cell adhesion molecule 1 ,GFP, green fluorescence protein ,COVID-19, coronavirus disease 2019 ,DSPC, distearoylphosphatidylcholine ,DPPC, dipalmitoylphosphatidylcholine ,LNP, lipid nanoparticle ,DOTAP, 1,2-dioleoyl-3-trimethylammonium propane ,mRNA1273, Moderna COVID-19 mRNA vaccine ,Gene Transfer Techniques ,eGFP, enhanced green fluorescence protein ,pDNA, plasmid DNA ,targeted therapy ,VEGF, vascular endothelial growth factor ,mRNA, messenger RNA ,GDNF, glial cell line–derived neurotrophic factor ,DSPE, 1,2-distearoyl-sn-glycero-3-phosphorylethanolamine ,Nurr1, orphan nuclear receptor ,BDNF, brain-derived neurotrophic factor ,MI, myocardial infarction ,shRNA, short hairpin RNA ,C4F10, decafluorobutane ,OTC, ornithine transcarbamylase ,SF6, sulfur hexafluoride ,Man-PEG2000, mannose-binding polyethylene glycol-2000 ,UTGD, ultrasound-targeted gene delivery ,Coronavirus disease 2019 (COVID-19) ,NB, nanobubble ,I/R, ischemia/reperfusion ,Computational biology ,Gene delivery ,CVD, cardiovascular disease ,AKT, protein kinase B ,SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 ,TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling ,Article ,Viral vector ,DSPC-PEG2K-Mal, distearoylphosphatidylcholine-N-[maleimide(polyethylene glycol)-2000] ,SPIO-NP, fluorinated iron oxide nanoparticle ,PEGylated-PEI-SH, polyethylene glycol-polyethylenimine-thiol ,Animals ,Humans ,Timp3, tissue inhibitor of metalloproteinase 3 ,Platelet activation ,DSTAP, 1,2-distearoyl-3-trimethylammonium-propane ,ComputingMethodologies_COMPUTERGRAPHICS ,PEG, polyethylene glycol ,TA, tibialis anterior ,AAA, abdominal aortic aneurysm ,MMP2, matrix metallopeptidase-2 ,PNA, peptide nucleic acid ,business.industry ,C3F8, octafluoropropane ,SCF, stem cell factor ,COVID-19 ,DC-CHOL, DC-cholesterol ,Genetic Therapy ,nucleic acid ,siRNA, small interfering RNA ,Liposomes ,IFN-β, interferon-β ,RNA, ribonucleic acid ,Nanoparticles ,Ultrasonic sensor ,PMO, phosphorodiamidate morpholino oligomer ,ultrasonic irradiation ,business ,Sonoporation ,MRI, magnetic resonance imaging ,MB, microbubble - Abstract
Graphical abstract, Gene therapy has been widely investigated for the treatment of genetic, acquired, and infectious diseases. Pioneering work utilized viral vectors; however, these are suspected of causing serious adverse events, resulting in the termination of several clinical trials. Non-viral vectors, such as lipid nanoparticles, have attracted significant interest, mainly due to their successful use in vaccines in the current COVID-19 pandemic. Although they allow safe delivery, they come with the disadvantage of off-target delivery. The application of ultrasound to ultrasound-sensitive particles allows for a direct, site-specific transfer of genetic materials into the organ/site of interest. This process, termed ultrasound-targeted gene delivery (UTGD), also increases cell membrane permeability and enhances gene uptake. This review focuses on the advances in ultrasound and the development of ultrasonic particles for UTGD across a range of diseases. Furthermore, we discuss the limitations and future perspectives of UTGD.
- Published
- 2021